179 related articles for article (PubMed ID: 22939523)
1. Susceptibility of canine and feline bacterial pathogens to pradofloxacin and comparison with other fluoroquinolones approved for companion animals.
Schink AK; Kadlec K; Hauschild T; Brenner Michael G; Dörner JC; Ludwig C; Werckenthin C; Hehnen HR; Stephan B; Schwarz S
Vet Microbiol; 2013 Feb; 162(1):119-26. PubMed ID: 22939523
[TBL] [Abstract][Full Text] [Related]
2. Comparison of pharmacodynamic and pharmacokinetic indices of efficacy for 5 fluoroquinolones toward pathogens of dogs and cats.
Boothe DM; Boeckh A; Simpson RB; Dubose K
J Vet Intern Med; 2006; 20(6):1297-306. PubMed ID: 17186841
[TBL] [Abstract][Full Text] [Related]
3. Resistance of canine methicillin-resistant Staphylococcus pseudintermedius strains to pradofloxacin.
Kizerwetter-Świda M; Chrobak-Chmiel D; Rzewuska M; Binek M
J Vet Diagn Invest; 2016 Sep; 28(5):514-8. PubMed ID: 27449131
[TBL] [Abstract][Full Text] [Related]
4. Comparative activity of pradofloxacin against anaerobic bacteria isolated from dogs and cats.
Silley P; Stephan B; Greife HA; Pridmore A
J Antimicrob Chemother; 2007 Nov; 60(5):999-1003. PubMed ID: 17872918
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of rapidly growing mycobacteria and Nocardia isolates from cats and dogs to pradofloxacin.
Govendir M; Norris JM; Hansen T; Wigney DI; Muscatello G; Trott DJ; Malik R
Vet Microbiol; 2011 Dec; 153(3-4):240-5. PubMed ID: 21726965
[TBL] [Abstract][Full Text] [Related]
6. In vitro potency and efficacy favor later generation fluoroquinolones for treatment of canine and feline Escherichia coli uropathogens in the United States.
Liu X; Boothe DM; Jin Y; Thungrat K
World J Microbiol Biotechnol; 2013 Feb; 29(2):347-54. PubMed ID: 23136054
[TBL] [Abstract][Full Text] [Related]
7. Survey of antimicrobial susceptibility of bacterial pathogens isolated from dogs and cats with respiratory tract infections in Europe: ComPath results.
Moyaert H; de Jong A; Simjee S; Rose M; Youala M; El Garch F; Vila T; Klein U; Rzewuska M; Morrissey I
J Appl Microbiol; 2019 Jul; 127(1):29-46. PubMed ID: 30955231
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and mechanisms of resistance to fluoroquinolones in Pseudomonas aeruginosa and Escherichia coli isolates recovered from dogs suffering from otitis in Greece.
Vingopoulou EI; Delis GA; Batzias GC; Kaltsogianni F; Koutinas A; Kristo I; Pournaras S; Saridomichelakis MN; Siarkou VI
Vet Microbiol; 2018 Jan; 213():102-107. PubMed ID: 29291992
[TBL] [Abstract][Full Text] [Related]
9. In vitro selection of resistance to pradofloxacin and ciprofloxacin in canine uropathogenic Escherichia coli isolates.
Liu X; Lazzaroni C; Aly SA; Thungrat K; Boothe DM
Vet Microbiol; 2014 Dec; 174(3-4):514-522. PubMed ID: 25465666
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial susceptibility monitoring of dermatological bacterial pathogens isolated from diseased dogs and cats across Europe (ComPath results).
Ludwig C; de Jong A; Moyaert H; El Garch F; Janes R; Klein U; Morrissey I; Thiry J; Youala M
J Appl Microbiol; 2016 Nov; 121(5):1254-1267. PubMed ID: 27593360
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial susceptibility monitoring of bacterial pathogens isolated from respiratory tract infections in dogs and cats across Europe: ComPath results.
Morrissey I; Moyaert H; de Jong A; El Garch F; Klein U; Ludwig C; Thiry J; Youala M
Vet Microbiol; 2016 Aug; 191():44-51. PubMed ID: 27374906
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of difloxacin against canine bacterial isolates.
van den Hoven R; Wagenaar JA; Walker RD
J Vet Diagn Invest; 2000 May; 12(3):218-23. PubMed ID: 10826834
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility of canine and feline Escherichia coli and canine Staphylococcus intermedius isolates to fluoroquinolones.
Gottlieb S; Wigney DI; Martin PA; Norris JM; Malik R; Govendir M
Aust Vet J; 2008 Apr; 86(4):147-52. PubMed ID: 18363989
[TBL] [Abstract][Full Text] [Related]
14. Mutant prevention concentration of orbifloxacin: comparison between Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus pseudintermedius of canine origin.
Shimizu T; Harada K; Kataoka Y
Acta Vet Scand; 2013 May; 55(1):37. PubMed ID: 23634902
[TBL] [Abstract][Full Text] [Related]
15. Fluoroquinolone resistance mechanisms in multidrug-resistant Escherichia coli isolated from extraintestinal infections in dogs.
Gibson JS; Cobbold RN; Kyaw-Tanner MT; Heisig P; Trott DJ
Vet Microbiol; 2010 Nov; 146(1-2):161-6. PubMed ID: 20471187
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial susceptibility monitoring of canine and feline skin and ear pathogens isolated from European veterinary clinics: results of the ComPath Surveillance programme.
de Jong A; Youala M; El Garch F; Simjee S; Rose M; Morrissey I; Moyaert H
Vet Dermatol; 2020 Dec; 31(6):431-e114. PubMed ID: 32924232
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial Susceptibility Monitoring of Bacterial Pathogens Isolated from Urinary Tract Infections in Dogs and Cats Across Europe: ComPath Results.
Moyaert H; Morrissey I; de Jong A; El Garch F; Klein U; Ludwig C; Thiry J; Youala M
Microb Drug Resist; 2017 Apr; 23(3):391-403. PubMed ID: 28384093
[TBL] [Abstract][Full Text] [Related]
18. Characterization of quinolone resistance mechanisms in Enterobacteriaceae isolated from companion animals in Europe (ComPath II study).
de Jong A; Muggeo A; El Garch F; Moyaert H; de Champs C; Guillard T
Vet Microbiol; 2018 Mar; 216():159-167. PubMed ID: 29519511
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial activity of marbofloxacin. A new fluoroquinolone for veterinary use against canine and feline isolates.
Spreng M; Deleforge J; Thomas V; Boisramé B; Drugeon H
J Vet Pharmacol Ther; 1995 Aug; 18(4):284-9. PubMed ID: 8583541
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms accounting for fluoroquinolone multidrug resistance Escherichia coli isolated from companion animals.
Liu X; Boothe DM; Thungrat K; Aly S
Vet Microbiol; 2012 Dec; 161(1-2):159-68. PubMed ID: 22877517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
